US › Healthcare

Opko Health Inc (OPK)

US · Healthcare · Diagnostics & Research

$1.310.00%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$163.6M
Revenue YoY
+4.3%
Net profit
$-8.4M
Profit YoY
+94.3%
EPS
$-0.01
EPS estimate
$-0.08
Net margin
-5.1%

EPS came in at -0.01 against a street estimate of -0.08 — a beat of 87.5%.

Key statistics

Market cap
$985.2M
Forward P/E
53.8
P/B
0.84
Book value
$1.59
EPS (TTM)
$-0.07
52-week high
$1.73
52-week low
$0.98
50-day MA
$1.38
200-day MA
$1.29
Beta
1.48

Analyst view

Analysts rate Opko Health Inc a buy (6 buy, 1 hold, 0 sell out of 7) with an average price target of $4.38.

Shareholding

Insiders
50.52%
Institutions
27.27%

Largest institutional holders

FundStake
Rubric Capital Management LP6.40%
BlackRock Inc4.85%
Vanguard Portfolio Management, LLC1.98%
Vanguard Capital Management, LLC1.94%
Geode Capital Management, LLC1.51%
State Street Corp1.27%
The Goldman Sachs Group Inc1.03%
UBS Group AG0.81%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Opko Health Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.